Skip to main content
Top
Published in: Infection 6/2017

01-12-2017 | Case Report

Low antibodies titer and serological cross-reaction between Coxiella burnetii and Legionella pneumophila challenge the diagnosis of mediastinitis, an emerging Q fever clinical entity

Authors: Sophie Edouard, Matthieu Million, Jean-Paul Casalta, Frédéric Collart, Bernard Amphoux, Didier Raoult

Published in: Infection | Issue 6/2017

Login to get access

Abstract

Background

Coxiella burnetii is an intracellular and fastidious bacterium responsible of acute and persistent Q fever infection. Endocarditis and vascular infections are the most common serious complications of acute Q fever.

Case report

We report the case of a 63-year-old man that presented a mediastinitis associated with a prosthetic vascular infection. Serological cross-reaction was observed between Coxiella burnetii, the agent of Q fever, and Legionella pneumophila with higher antibodies titer for L. pneumophila (IgG = 1:512) than for C. burnetii (phase I IgG = 1:400). We performed western blot with cross-adsorption that supports the diagnosis of C. burnetii infection. Two weeks later, a positive qPCR and culture for C. burnetii on swab taken from the mediastinal cutaneous fistula confirmed the definitive microbiological diagnosis of Q fever mediastinitis.

Conclusion

Cross-reactivity between C. burnetii and Legionella spp. has long been known and should be considered in patients with persistent infections. It is important to establish the definite diagnosis because the antibiotic treatment regimens and duration are significantly different. To the best of our knowledge, we reported here the first case of mediastinitis associated to C. burnetii and we diagnosed this persistent infection despite low anti-C. burnetii phase I IgG levels.
Literature
1.
go back to reference Raoult D, Casalta JP, Richet H, et al. Contribution of systematic serological testing in diagnosis of infective endocarditis. J Clin Microbiol. 2005;43:5238–42.CrossRefPubMedPubMedCentral Raoult D, Casalta JP, Richet H, et al. Contribution of systematic serological testing in diagnosis of infective endocarditis. J Clin Microbiol. 2005;43:5238–42.CrossRefPubMedPubMedCentral
2.
go back to reference Fournier PE, Thuny F, Richet H, Lepidi H, Casalta JP, Arzouni JP, et al. Comprehensive diagnostic strategy for blood culture-negative endocarditis: a prospective study of 819 new cases. Clin Infect Dis. 2010;51:131–40.CrossRefPubMed Fournier PE, Thuny F, Richet H, Lepidi H, Casalta JP, Arzouni JP, et al. Comprehensive diagnostic strategy for blood culture-negative endocarditis: a prospective study of 819 new cases. Clin Infect Dis. 2010;51:131–40.CrossRefPubMed
3.
go back to reference Eldin C, Melenotte C, Mediannikov O, Ghigo E, Million M, Edouard S, et al. From Q fever to Coxiella burnetii infection: a paradigm change. Clin Microbiol Rev. 2017;30:115–90.CrossRefPubMed Eldin C, Melenotte C, Mediannikov O, Ghigo E, Million M, Edouard S, et al. From Q fever to Coxiella burnetii infection: a paradigm change. Clin Microbiol Rev. 2017;30:115–90.CrossRefPubMed
4.
go back to reference Edouard S, Million M, Lepidi H, et al. Persistence of DNA in a cured patient and positive culture in cases with low antibody levels bring into question diagnosis of Q fever endocarditis. J Clin Microbiol. 2013;51:3012–7.CrossRefPubMedPubMedCentral Edouard S, Million M, Lepidi H, et al. Persistence of DNA in a cured patient and positive culture in cases with low antibody levels bring into question diagnosis of Q fever endocarditis. J Clin Microbiol. 2013;51:3012–7.CrossRefPubMedPubMedCentral
5.
go back to reference Eldin C, Angelakis E, Renvoise A, Raoult D. Coxiella burnetii DNA, but not viable bacteria, in dairy products in France. Am J Trop Med Hyg. 2013;88:765–9.CrossRefPubMedPubMedCentral Eldin C, Angelakis E, Renvoise A, Raoult D. Coxiella burnetii DNA, but not viable bacteria, in dairy products in France. Am J Trop Med Hyg. 2013;88:765–9.CrossRefPubMedPubMedCentral
6.
go back to reference Brusch JL. Legionnaire’s disease: cardiac manifestations. Infect Dis Clin N Am. 2017;31:69–80.CrossRef Brusch JL. Legionnaire’s disease: cardiac manifestations. Infect Dis Clin N Am. 2017;31:69–80.CrossRef
7.
go back to reference Million M, Thuny F, Richet H, Raoult D. Long-term outcome of Q fever endocarditis: a 26-year personal survey. Lancet Infect Dis. 2010;10:527–35.CrossRefPubMed Million M, Thuny F, Richet H, Raoult D. Long-term outcome of Q fever endocarditis: a 26-year personal survey. Lancet Infect Dis. 2010;10:527–35.CrossRefPubMed
8.
go back to reference Finidori JP, Raoult D, Bornstein N, Fleurette J. Study of cross-reaction between Coxiella burnetii and Legionella pneumophila using indirect immunofluorescence assay and immunoblotting. Acta Virol. 1992;36:459–65.PubMed Finidori JP, Raoult D, Bornstein N, Fleurette J. Study of cross-reaction between Coxiella burnetii and Legionella pneumophila using indirect immunofluorescence assay and immunoblotting. Acta Virol. 1992;36:459–65.PubMed
9.
go back to reference Keijmel SP, Raijmakers RP, Schoffelen T, Salet MC, Bleeker-Rovers CP. A fatal case of disseminated chronic Q fever: a case report and brief review of the literature. Infection. 2016;44:677–82.CrossRefPubMedPubMedCentral Keijmel SP, Raijmakers RP, Schoffelen T, Salet MC, Bleeker-Rovers CP. A fatal case of disseminated chronic Q fever: a case report and brief review of the literature. Infection. 2016;44:677–82.CrossRefPubMedPubMedCentral
10.
go back to reference Raoult D. Chronic Q fever: expert opinion versus literature analysis and consensus. J Infect. 2012;65:102–8.CrossRefPubMed Raoult D. Chronic Q fever: expert opinion versus literature analysis and consensus. J Infect. 2012;65:102–8.CrossRefPubMed
11.
go back to reference Grisoli D, Million M, Edouard S, Thuny F, Lepidi H, Collart F, et al. Latent Q fever endocarditis in patients undergoing routine valve surgery. J Heart Valve Dis. 2014;23:735–43.PubMed Grisoli D, Million M, Edouard S, Thuny F, Lepidi H, Collart F, et al. Latent Q fever endocarditis in patients undergoing routine valve surgery. J Heart Valve Dis. 2014;23:735–43.PubMed
12.
13.
go back to reference Musso D, Raoult D. Serological cross-reactions between Coxiella burnetii and Legionella micdadei. Clin Diagn Lab Immunol. 1997;4:208–12.PubMedPubMedCentral Musso D, Raoult D. Serological cross-reactions between Coxiella burnetii and Legionella micdadei. Clin Diagn Lab Immunol. 1997;4:208–12.PubMedPubMedCentral
14.
go back to reference Lieberman D, Lieberman D, Boldur I, et al. Q-fever pneumonia in the Negev region of Israel: a review of 20 patients hospitalised over a period of one year. J Infect. 1995;30:135–40.CrossRefPubMed Lieberman D, Lieberman D, Boldur I, et al. Q-fever pneumonia in the Negev region of Israel: a review of 20 patients hospitalised over a period of one year. J Infect. 1995;30:135–40.CrossRefPubMed
15.
go back to reference La Scola B, Raoult D. Serological cross-reactions between Bartonella quintana, Bartonella henselae, and Coxiella burnetii. J Clin Microbiol. 1996;34:2270–4.PubMedPubMedCentral La Scola B, Raoult D. Serological cross-reactions between Bartonella quintana, Bartonella henselae, and Coxiella burnetii. J Clin Microbiol. 1996;34:2270–4.PubMedPubMedCentral
Metadata
Title
Low antibodies titer and serological cross-reaction between Coxiella burnetii and Legionella pneumophila challenge the diagnosis of mediastinitis, an emerging Q fever clinical entity
Authors
Sophie Edouard
Matthieu Million
Jean-Paul Casalta
Frédéric Collart
Bernard Amphoux
Didier Raoult
Publication date
01-12-2017
Publisher
Springer Berlin Heidelberg
Published in
Infection / Issue 6/2017
Print ISSN: 0300-8126
Electronic ISSN: 1439-0973
DOI
https://doi.org/10.1007/s15010-017-1048-6

Other articles of this Issue 6/2017

Infection 6/2017 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine